首页 › 基金 › BOONE CAPITAL MANAGEMENT LLC › KYMR

BOONE CAPITAL MANAGEMENT LLC 对 KYMR 的持仓历史

KYMERA THERAPEUTICS INC · 医疗保健

BOONE CAPITAL MANAGEMENT LLC 在 Q2 2026 的 13F 申报中披露持有 KYMR(KYMERA THERAPEUTICS INC)113,173 股,市值约 US$13.0M,约占其申报组合的 3.04%,在其申报持仓中市值排名第 14 位。 BOONE CAPITAL MANAGEMENT LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)113.17K 股
申报持仓市值$12.98M
组合权重3.04%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

BOONE CAPITAL MANAGEMENT LLC 对 KYMR 的持仓演变

BOONE CAPITAL MANAGEMENT LLC 于 Q2 2026 首次披露 KYMR 持仓:113,173 股(约 US$13.0M)。

逐季持仓明细

季度股数金额变化
Q2 2026 113.17K $12.98M 新进

关于 KYMR 与 13F 数据

KYMR(KYMERA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 58 只申报持有 KYMR,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 KYMR 的基金

查看 KYMR 的全部基金持有人 →

常见问题

How long has BOONE CAPITAL MANAGEMENT LLC held KYMR?

BOONE CAPITAL MANAGEMENT LLC has disclosed KYMR holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is BOONE CAPITAL MANAGEMENT LLC's current position in KYMR?

As of Q2 2026, BOONE CAPITAL MANAGEMENT LLC holds 113.17K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $12.98M, representing 3.04% of its reported portfolio and ranking #14.

Has BOONE CAPITAL MANAGEMENT LLC been buying or selling KYMR?

In the latest 13F filing (Q2 2026), BOONE CAPITAL MANAGEMENT LLC newly opened its position in KYMR.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.